Atrás
35
Rango del Día
$12.91
$13.44
Rango de 52 Semanas
$12.50
$21.89
Volumen
595,493
Promedio 50D / 200D
$15.68
/
$16.73
Cierre Anterior
$12.79
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -30.3 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | -11.0 | 3.7 |
| Net Margin % | -9.4 | 3.8 |
| Rev Growth 5Y % | 22.2 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue grew 22.18% annually over 5 years — strong growth
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of -9.09M
Capital efficient — spends only 4.19% of revenue on capex
Crecimiento
Revenue Growth (5Y)
22.18%
Revenue (1Y)20.19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-10.98%
ROIC-9.37%
Net Margin-9.41%
Op. Margin-11.11%
Seguridad
Debt / Equity
0.01
Current Ratio8.55
Interest Coverage-4.23
Valoración
P/E Ratio
-30.34
P/B Ratio3.23
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.19% | Revenue Growth (3Y) | 20.28% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 22.18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 200.93M | Net Income (TTM) | -18.91M |
| ROE | -10.98% | ROA | -7.93% |
| Gross Margin | 79.57% | Operating Margin | -11.11% |
| Net Margin | -9.41% | Free Cash Flow (TTM) | -9.09M |
| ROIC | -9.37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 8.55 |
| Interest Coverage | -4.23 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -30.34 | P/B Ratio | 3.23 |
| P/S Ratio | 2.86 | PEG Ratio | 1.10 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 573.71M | Enterprise Value | 532.59M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200.93M | 167.18M | 138.89M | 106.41M | 90.15M |
| Net Income | -18.91M | -30.91M | -43.34M | -61.26M | -56.57M |
| EPS (Diluted) | -0.44 | -0.75 | -1.13 | -1.79 | -1.71 |
| Gross Profit | 159.88M | 132.12M | 109.42M | 90.70M | 79.72M |
| Operating Income | -22.33M | -35.25M | -46.93M | -59.61M | -51.67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 238.56M | 230.44M | 230.43M | 157.55M | 190.51M |
| Total Liabilities | 61.02M | 63.47M | 61.05M | 59.25M | 56.09M |
| Shareholders' Equity | 177.53M | 166.96M | 169.38M | 98.30M | 134.42M |
| Total Debt | 1.12M | 37.48M | 38.99M | 39.43M | 40.48M |
| Cash & Equivalents | 42.24M | 34.95M | 33.27M | 20.72M | 63.42M |
| Current Assets | 216.12M | 207.78M | 211.39M | 137.61M | 175.87M |
| Current Liabilities | 25.28M | 27.13M | 23.46M | 21.18M | 16.89M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#98 of 146
Actividad Reciente
Entró
Full Throttle
Mar 24, 2026